BR112022018613A2 - Comprimido, medicamento, métodos para a produção destes e kit - Google Patents

Comprimido, medicamento, métodos para a produção destes e kit

Info

Publication number
BR112022018613A2
BR112022018613A2 BR112022018613A BR112022018613A BR112022018613A2 BR 112022018613 A2 BR112022018613 A2 BR 112022018613A2 BR 112022018613 A BR112022018613 A BR 112022018613A BR 112022018613 A BR112022018613 A BR 112022018613A BR 112022018613 A2 BR112022018613 A2 BR 112022018613A2
Authority
BR
Brazil
Prior art keywords
pills
kit
drug
production
methods
Prior art date
Application number
BR112022018613A
Other languages
English (en)
Inventor
SANO Shusuke
Arase Shuntaro
Shikata Futoshi
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of BR112022018613A2 publication Critical patent/BR112022018613A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPRIMIDO, MEDICAMENTO, MÉTODOS PARA A PRODUÇÃO DESTES E KIT. Um objetivo da presente invenção é fornecer um comprimido com excelente permeabilidade e retenção de ingredientes farmacêuticos ativos. Este objetivo pode ser alcançado com um comprimido a ser impregnado com um ingrediente farmacêutico ativo, em que o comprimido compreende um monossacarídeo e/ou dissacarídeo.
BR112022018613A 2020-03-31 2021-03-29 Comprimido, medicamento, métodos para a produção destes e kit BR112022018613A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020062818 2020-03-31
PCT/JP2021/013162 WO2021200767A1 (ja) 2020-03-31 2021-03-29 錠剤、医薬及びそれらの製造方法並びにキット

Publications (1)

Publication Number Publication Date
BR112022018613A2 true BR112022018613A2 (pt) 2022-11-08

Family

ID=77929439

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022018613A BR112022018613A2 (pt) 2020-03-31 2021-03-29 Comprimido, medicamento, métodos para a produção destes e kit

Country Status (11)

Country Link
US (1) US20230105591A1 (pt)
EP (1) EP4129342A4 (pt)
JP (1) JPWO2021200767A1 (pt)
KR (1) KR20220161285A (pt)
CN (1) CN115243723A (pt)
AU (1) AU2021250160A1 (pt)
BR (1) BR112022018613A2 (pt)
CA (1) CA3174773A1 (pt)
MX (1) MX2022011215A (pt)
TW (1) TW202203971A (pt)
WO (1) WO2021200767A1 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2922522A1 (de) * 1979-06-01 1980-12-04 Dudzik Joachim Tablette
JP3534130B2 (ja) * 1994-03-01 2004-06-07 旭化成ケミカルズ株式会社 医薬品組成物
US6399591B1 (en) * 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
US20060134202A1 (en) * 2004-12-22 2006-06-22 Hack Jacob C Homeopathic sublingual dosage forms and methods thereof
DK1973529T3 (da) * 2006-01-05 2011-09-12 Veloxis Pharmaceuticals As Fyldbar tablet, som er i stand til at falde hen
DK2209501T3 (da) * 2007-10-12 2012-02-27 Astrazeneca Ab Zibotentan-sammensætning, der indeholder mannitol og mikrokrystallinsk cellulose

Also Published As

Publication number Publication date
MX2022011215A (es) 2022-10-07
EP4129342A4 (en) 2024-03-06
TW202203971A (zh) 2022-02-01
CA3174773A1 (en) 2021-10-07
CN115243723A (zh) 2022-10-25
KR20220161285A (ko) 2022-12-06
EP4129342A1 (en) 2023-02-08
JPWO2021200767A1 (pt) 2021-10-07
AU2021250160A1 (en) 2022-10-06
US20230105591A1 (en) 2023-04-06
WO2021200767A1 (ja) 2021-10-07

Similar Documents

Publication Publication Date Title
MX2020007625A (es) Inhibidor mtor, composicion farmaceutica y su uso.
BR112019015904A2 (pt) Sistemas e métodos para a fabricação de comprimidos, incluindo comprimidos farmacêuticos
BR112018069483A2 (pt) pró-fármacos de medicamentos citotóxicos contendo grupos enzimaticamente cliváveis.
BR112016014830A2 (pt) Conjugados de fármaco de anticorpo (adcs) com inibidores de ksp
UY37705A (es) Nuevos derivados de pirazol bicíclicos
BR112022012514A2 (pt) Formas de dosagem sólidas que contêm bactérias e vesículas extracelulares microbianas
CO2017002682A2 (es) Composiciones y métodos para recubrimientos cannabinoides para uso en la entrega de fármacos
BR112015010980A2 (pt) composição de excipientes e formas farmacêuticas de libertação prolongada com aumento de biodisponibilidade de drogas antibacterianas, drogas anticoccidianas e outros medicamentos para aves e suínos comerciais
BR112017020307A2 (pt) método para inibir os sintomas associados com a ingestão de álcool, e, composição farmacêutica
BR112018002520A2 (pt) Agonistas de tlr4 e composições dos mesmos e seuuso no tratamento de câncer
BR112022008000A2 (pt) Derivado de pirazol-heteroarila, método de preparação para o mesmo e uso médico do mesmo
BR112019024260A2 (pt) composições que compreende derivados de naftiridina e adjuvante de aluminio para uso no tratamento de tumores solidos
BR112022018613A2 (pt) Comprimido, medicamento, métodos para a produção destes e kit
BR112018015851A2 (pt) composto, e, medicamento.
BR112022014456A2 (pt) Tafoxiparina para o tratamento da pré-eclâmpsia
BR112015020237A2 (pt) comprimido com revestimento entérico
BR112018067613A2 (pt) composição farmacêutica anti-abuso
BR112022013741A2 (pt) Composição farmacêutica
BR112018009279A2 (pt) compostos de oxadiazaespiro para o tratamento de abuso de droga e adicção
BR112019022459A2 (pt) Agente terapêutico para câncer no sangue
BR112015028302A2 (pt) formulação de pastilha de nicotina
BR112021020951A2 (pt) Dispensação e retenção de agentes ativos dentro da pele
BR112021021841A2 (pt) Formulação de pó para administração intranasal, e método de fabricação da mesma
WO2019004984A3 (en) PHARMACEUTICAL FORMULATION COMPRISING CHOLECALCIFEROL
BR112023006143A2 (pt) Composição farmacêutica para prevenir ou tratar doença hepática colestática, contendo beta-lapachona como ingrediente ativo